Vma3 (YCR061W) is a 16 kDa transmembrane protein essential for V-ATPase assembly and proton transport across vacuolar membranes . The V-ATPase complex acidifies intracellular compartments, enabling processes like protein degradation, ion homeostasis, and stress adaptation.
YCR061W Antibody is primarily used to:
Studies using YCR061W knockout strains revealed its critical role in oxidative stress tolerance. Under methylcyclohexane methanol (MCHM)-induced stress:
Vma3-deficient cells showed impaired growth and increased reactive oxygen species (ROS) .
Cell cycle analysis indicated G1 arrest in wild-type cells exposed to MCHM, while vma3Δ mutants exhibited dysregulated progression .
| Parameter | Wild-Type (BY4741) | vma3Δ Mutant |
|---|---|---|
| Viability under MCHM | 85% ± 3% | 45% ± 5% |
| ROS Accumulation | 12% ± 2% | 38% ± 4% |
| G1 Arrest (550 ppm MCHM) | 68% ± 5% | 22% ± 3% |
The TRIPLES database provides extensive data on YCR061W mutagenesis:
Transposon insertions in YCR061W were linked to altered sporulation efficiency and meiosis progression .
Epitope-tagged Vma3 localized to vacuolar membranes, confirmed via immunofluorescence .
While no commercial YCR061W antibody is explicitly described, related methodologies highlight best practices:
Epitope tagging (e.g., HA or FLAG) combined with monoclonal antibodies ensures specific detection .
Cross-reactivity screens using peptide arrays (e.g., PEPperMAP®) minimize off-target binding .
KEGG: sce:YCR061W
STRING: 4932.YCR061W
YCR061W is a protein encoded by the YCR061W gene found in Saccharomyces cerevisiae (baker's yeast), specifically in the reference strain ATCC 204508 / S288c. According to the UniProt database, this protein is associated with accession number P25639. The nomenclature follows standard yeast gene naming conventions where "Y" indicates a yeast gene, "CR" refers to chromosome III, and "061W" indicates it is the 61st open reading frame on the Watson (W) strand of that chromosome .
YCR061W Antibody is primarily used in various research applications including:
Western blotting for protein expression analysis
Immunoprecipitation for protein interaction studies
Immunofluorescence microscopy for subcellular localization
ELISA assays for quantitative detection
ChIP assays (if the protein has DNA-binding properties)
Flow cytometry for cell-based analysis
The antibody is specifically designed for detecting YCR061W protein in Saccharomyces cerevisiae (strain ATCC 204508 / S288c). It can be used with various yeast sample preparations including:
Whole cell lysates
Subcellular fractions
Purified protein preparations
Fixed yeast cells for microscopy
Yeast spheroplasts
While specific optimization is necessary for each research setting, a general protocol for Western blotting with yeast proteins includes:
Sample Preparation:
Harvest yeast cells at appropriate growth phase
Lyse cells using glass bead disruption in appropriate buffer
Clear lysate by centrifugation (14,000g, 10 minutes, 4°C)
Quantify protein concentration using Bradford or BCA assay
Western Blotting:
Separate proteins by SDS-PAGE (10-12% gel recommended)
Transfer to PVDF or nitrocellulose membrane (wet transfer recommended)
Block with 5% non-fat milk in TBST for 1 hour at room temperature
Incubate with YCR061W Antibody (initial dilution 1:1000) overnight at 4°C
Wash 3x with TBST
Incubate with appropriate HRP-conjugated secondary antibody (1:5000) for 1 hour
Develop using ECL substrate and image
For immunoprecipitation of YCR061W from yeast lysates:
Prepare yeast lysate in non-denaturing buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, protease inhibitors)
Pre-clear lysate with Protein A/G beads for 1 hour at 4°C
Incubate cleared lysate with YCR061W Antibody (2-5 μg per mg of total protein) overnight at 4°C
Add fresh Protein A/G beads and incubate for 2-3 hours at 4°C
Wash beads 4-5 times with wash buffer (increasing stringency)
Elute bound proteins with SDS sample buffer (95°C, 5 minutes)
Analyze by SDS-PAGE and Western blotting
For immunofluorescence microscopy of yeast cells:
Fix yeast cells with 3.7% formaldehyde for 30-60 minutes
Prepare spheroplasts using zymolyase (1 mg/ml, 30 minutes at 30°C)
Permeabilize with 0.1% Triton X-100 for 10 minutes
Block with 3% BSA in PBS for 30 minutes
Incubate with YCR061W Antibody (1:100-1:500 dilution) for 2 hours or overnight
Wash 3x with PBS
Incubate with fluorophore-conjugated secondary antibody (1:500-1:1000) for 1 hour
Counterstain nucleus with DAPI (1 μg/ml) for 5 minutes
Mount and image using appropriate filters
For maximum longevity and performance:
Upon receipt, aliquot the antibody to minimize freeze-thaw cycles
Store aliquots at -20°C for long-term storage
Working stock can be kept at 4°C for up to 2 weeks
Add sodium azide (0.02%) as preservative for longer storage at 4°C
Avoid repeated freeze-thaw cycles
Centrifuge briefly before opening to collect liquid at the bottom of the tube
When experiencing weak or absent signals with YCR061W Antibody:
Increase protein loading amount (up to 50-100 μg)
Optimize antibody concentration (try serial dilutions)
Extend primary antibody incubation time (overnight at 4°C)
Use more sensitive detection systems (ECL Plus, fluorescent detection)
Verify protein expression level in your sample
Check for protein degradation during sample preparation
Try different extraction methods to improve protein solubility
Ensure the epitope is not masked by protein folding or modifications
To improve specificity:
Optimize blocking conditions (test different blockers: milk, BSA, serum)
Increase washing stringency (higher salt, mild detergents)
Pre-adsorb antibody with acetone powder from yeast lacking YCR061W
Titrate antibody concentration to minimum effective level
Use more specific secondary antibodies
Include appropriate controls (knockout strains where available)
Consider using affinity-purified antibody preparations
For investigating protein-protein interactions:
Co-immunoprecipitation (Co-IP):
Use YCR061W Antibody to pull down protein complexes
Detect interacting partners by Western blotting with specific antibodies
Confirm interactions with reciprocal IPs
Proximity Ligation Assay (PLA):
Combine YCR061W Antibody with antibody against suspected interacting partner
Use PLA probes and detection system to visualize interactions in situ
Immunofluorescence co-localization:
Perform dual staining with YCR061W Antibody and antibodies against potential partners
Analyze co-localization using confocal microscopy and quantitative image analysis
Advanced techniques for epitope characterization include:
Peptide array analysis:
Synthesize overlapping peptides spanning YCR061W sequence
Test antibody binding to identify specific recognition regions
Deletion mapping:
Create truncated versions of YCR061W protein
Test recognition by Western blotting to narrow down epitope region
Site-directed mutagenesis:
Introduce specific amino acid changes in the predicted epitope region
Assess impact on antibody binding to identify critical residues
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
Identify regions protected from exchange when antibody is bound
Provides structural information about the epitope
When working with mutant strains:
Confirm the mutation doesn't affect the epitope recognized by the antibody
Use appropriate wild-type controls processed in parallel
Account for potential changes in protein expression levels
Consider compensatory mechanisms that might affect interpretation
Verify strain identity and mutation through genotyping
Control for differences in growth conditions or stress responses
Normalize to appropriate loading controls not affected by the mutation
Rigorous validation approaches include:
Testing in YCR061W knockout or knockdown strains (negative control)
Overexpression systems to confirm increased signal (positive control)
Pre-absorption with purified antigen or epitope peptides
Western blot analysis confirming a single band at the expected molecular weight
Mass spectrometry confirmation of immunoprecipitated proteins
Comparison with results from orthogonal techniques (e.g., GFP-tagging)
Cross-reactivity testing with closely related proteins
Essential controls include:
Positive control:
Wild-type yeast strain known to express YCR061W
Recombinant YCR061W protein (if available)
Negative control:
YCR061W deletion strain (if available)
Secondary antibody only (no primary antibody)
Isotype control (irrelevant antibody of same isotype)
Validation controls:
Peptide competition assay
Loading controls for Western blotting (e.g., actin, GAPDH)
Subcellular marker controls for localization studies
For reproducibility and troubleshooting, record:
| Parameter | Details to Document |
|---|---|
| Antibody | Manufacturer, catalog number, lot number, host species, clonality |
| Dilution | Working concentration used for each application |
| Incubation | Time, temperature, buffer composition |
| Sample | Strain background, growth conditions, preparation method |
| Detection | System used, exposure time, instrument settings |
| Controls | All positive and negative controls included |
| Results | Band size, localization pattern, quantification method |
Integrating antibody-based detection with genetic methods:
Correlate protein levels with phenotypes in different genetic backgrounds
Combine with CRISPR-Cas9 genome editing to study effects of specific mutations
Use in synthetic genetic array analysis to identify genetic interactions
Analyze protein expression in response to specific gene deletions or overexpression
Study post-translational modifications in different genetic backgrounds
Multi-omics integration strategies include:
Proteomics integration:
Mass spectrometry analysis of immunoprecipitated complexes
Correlation of antibody-detected levels with global proteome changes
Transcriptomics correlation:
Compare protein levels detected by antibody with mRNA expression data
Investigate post-transcriptional regulation mechanisms
Metabolomics connection:
Correlate YCR061W protein levels with metabolic changes
Investigate role in specific metabolic pathways
Structural biology:
Use antibody in protein purification for structural studies
Epitope mapping for structural domain analysis
For improved immunofluorescence results:
Optimize fixation method and duration (formaldehyde vs. methanol)
Test different cell wall digestion conditions for optimal spheroplasting
Try various permeabilization agents and concentrations
Experiment with different blocking reagents (BSA, normal serum, casein)
Test a range of antibody dilutions and incubation times
Use high-quality fluorescent secondary antibodies
Include appropriate counterstains for reference structures
Employ confocal microscopy for improved resolution
To improve immunoprecipitation results:
Test different lysis buffers to optimize protein extraction
Vary antibody amounts (1-10 μg per mg of total protein)
Adjust antibody incubation time (2 hours to overnight)
Test different types of beads (Protein A, Protein G, or magnetic beads)
Optimize washing stringency to balance specificity and yield
Consider crosslinking antibody to beads to prevent antibody elution
Use gentler elution methods for co-IP applications
Scale up reaction for low-abundance targets
Yeast-specific validation approaches:
Use gene deletion library strains to confirm absence of signal
Employ epitope-tagged versions of YCR061W for parallel detection
Utilize yeast two-hybrid system to confirm detected interactions
Perform peptide competition assays with synthetic yeast peptides
Compare reactivity across different yeast species with known sequence homology
Use temperature-sensitive mutants to correlate protein function with detection
Critical variables to control:
Growth conditions:
Growth phase (log vs. stationary)
Carbon source (glucose, galactose, glycerol)
Nutrient availability and limitations
Temperature and pH
Sample preparation:
Lysis method efficiency
Buffer composition and pH
Protease inhibitor cocktail inclusion
Sample handling temperature
Detection parameters:
Primary antibody concentration
Incubation time and temperature
Secondary antibody selection
Signal development method
When facing data inconsistencies:
Verify antibody integrity (test new aliquot or lot)
Confirm strain identity through genotyping
Check for experimental variables that might differ between experiments
Test alternative detection methods for the same protein
Consider post-translational modifications that might affect detection
Evaluate potential changes in protein localization or solubility
Consult literature for known issues with this protein class
Consider biological variability in expression levels
For reliable quantitation:
Establish linear detection range through standard curves
Use appropriate normalization controls (housekeeping proteins)
Perform technical and biological replicates
Control loading amount precisely
Use digital image acquisition with appropriate dynamic range
Avoid signal saturation during image acquisition
Apply appropriate statistical analysis methods
Consider factors affecting protein stability and turnover